Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Blood System Drugs (Find 9 items)

Blood System Drugs

Diosmin

(520-27-4)
1. Vascular protectant
2. Naturally occurring flavonic glycoside; rhamnoglycoside of Diosmetin. Capillary protectant

Product List

Request for quotation , get quotes from more suppliers.

Dextran

(9004-54-0)
Substance is used in soft center confections, as a partial substitute for barley malt. Anti-anemia drugs. Used for iron deficiency anemia. Adverse reactions and contraindications If the hemoglobin does not gradually increase after injection of this product, the drug should be stopped immediately. Avoid use in patients with liver and kidney dysfunction. Blood volume supplement medicine. Adverse reactions and contraindications occasionally allergic reactions. It is forbidden for patients with con

Product List

Request for quotation , get quotes from more suppliers.

Dabigatran

(211914-51-1)
Nonpeptide, direct thrombin inhibitor. Antithrombotic.

Product List

Request for quotation , get quotes from more suppliers.

Dabigatran etexilate

(211915-06-9)
BIBR-1048 (Dabigatran) is an anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in many cases it offers an alternative to warfarin as the preferred orally administered blood thinner sin

Product List

Request for quotation , get quotes from more suppliers.

Dabigatran etexilate mesylate

(872728-81-9)
Nonpeptide, direct thrombin inhibitor. Antithrombotic. Dabigatran etexilate mesylate is a raw material for the blood system; an anticoagulant drug; it can be used in patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism; dabigatran etexilate is a new type of synthetic Direct thrombin inhibitor, a prodrug of dabigatran, is a non-peptide thrombin inhibitor. Security Information

Product List

Request for quotation , get quotes from more suppliers.

Deferasirox

(201530-41-8)
Labeled Deferasirox, intended for use as an internal standard for the quantification of Deferasirox by GC- or LC-mass spectrometry.

Product List

Request for quotation , get quotes from more suppliers.

Dazoxiben

(78218-09-4)
Selective TVA2 (thrombus A2) synthase inhibitor, selective thromboxane A2 synthase inhibitor. It is used to treat angina pectoris, and is used for the treatment of thromboembolic diseases such as myocardial infarction and Raynaud~"s disease.

Product List

Request for quotation , get quotes from more suppliers.

Daltroban

(79094-20-5)
It is a specific and powerful antagonist of thromboxane A2 receptor, which can inhibit platelet aggregation, affect thrombosis and prevent sudden death. It is used to treat myocardial ischemia, hemorrhagic shock, endotoxic shock, sudden cardiopulmonary death, acute renal failure, atherosclerosis, etc.

Product List

Request for quotation , get quotes from more suppliers.

Hematological diseases refer to diseases that are primary (such as leukemia) or mainly involve blood (such as iron deficiency anemia) and hematopoietic organs. Classification: red blood cell diseases, such as various types of anemia and polycythemia, etc .; granulocyte diseases, such as leukopenia and agranulocytosis, neutrophil lobular insufficiency, inert leukocyte syndrome, and leukemia-like reactions. Blood system drugs mainly include: anti-anemic drugs, leukocyte-raising drugs, antiplatelet drugs, procoagulant drugs, anticoagulant drugs and thrombolytic drugs, blood volume expansion agents, leukocyte-raising drugs, antiplatelet drugs and other drugs. The "Blood System Drugs" on ECHEMI classification list mainly supplies APIs for these drugs.
Complaint
Email:
Message:
Send Message